The immunohistochemistry test detects the folate receptor 1 protein, which is over-expressed in most ovarian cancers.

Roche has secured CE mark approval for its immunohistochemistry (IHC) companion diagnostic test, VENTANA FOLR1 (FOLR1-2.1) ...

Executive Vice-President of Diagnostics, Africa, at Roche Diagnostics, Dr. Allan Pamba, has urged action against diabetes. He said November is World Diabetes Awareness month, noting non-communicable ...

Swiss drug major Roche Group (RHHBY) announced Monday that it has received CE Mark for its VENTANA FOLR1 (FOLR1-2.1) RxDx Assay, ...

MANSFIELD — Roche Bros Supermarkets Inc., a 20-store eastern Massachusetts grocery chain under the Roche Bros., Sudbury Farms and Brothers Marketplace banners, said it has entered into a ...

Presented at the Clinical Trials in Alzheimer’s Disease congress, being held in Madrid, Spain, Roche’s diagnostics unit showed that a negative result from one test—its Elecsys amyloid plasma ...

Founded in 1896 in Basel, Switzerland, as one of the first industrial manufacturers of branded medicines, Roche has grown into the world’s largest biotechnology company and the global leader in ...

Here’s how it works. Ultra runner David Roche got back on the course this weekend to prove that his Leadville 100 win was no fluke. The runner snatched victory at The Javelina Jundred yesterday, just ...

Healthcare solutions provider Qure.ai has entered into a collaboration with Roche Diagnostics Asia Pacific’s Startup Creasphere (APAC) initiative to work on AI-driven medical imaging technologies.

One could argue this is meant as a slight deterrent for people wishing to run car diagnostics at home. There is a difference between readers and scanners The most obvious difference between code ...

New optical technique could revolutionize medical diagnostics. ScienceDaily . Retrieved November 19, 2024 from www.sciencedaily.com / releases / 2024 / 10 / 241025122429.htm ...

But given the new products that we're launching we are confident also about the outlook in Diagnostics. Here you see the key growth drivers of the Roche portfolio in the quarter and going forward.